{
  "cycle": "v2-4",
  "updated": "2026-02-10T23:59:00Z",
  "total_signals": 28,
  "signals_above_threshold": 26,
  "signals_forwarded_to_agent_b": 24,
  "recent_signals": [
    {
      "id": "A-v2-4-001",
      "headline": "O*NET Polanyi Screen: Bookkeepers 91% automation risk (1.5M jobs, $47K median). Tax Preparers 99% (82K jobs, $49K). Accountants 67% (1.4M jobs, $80K).",
      "structural_shift": "Polanyi Classification VALIDATED with real O*NET/WillRobotsTakeMyJob data",
      "source": "O*NET / WillRobotsTakeMyJob / BLS OES May 2024",
      "source_url": "https://willrobotstakemyjob.com/bookkeeping-accounting-and-auditing-clerks",
      "relevance_score": 10,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "production_cost_shift",
      "barriers_noted": [],
      "category": "services",
      "detail": "COMPREHENSIVE O*NET POLANYI SCREEN across 15 occupations. ACCOUNTING: Bookkeepers 91% automation (1,501,910 employed, $47,440 median) -- 'no important qualities that can't be easily automated'. Tax Preparers 99% (81,650 employed, $49,010). Accountants 67% (1,435,770 employed, $79,880) -- judgment tasks provide 33% automation resistance. COMBINED Baumol Cure target: 3M+ workers, $140B+ annual wage bill. Bookkeepers are the SINGLE LARGEST Baumol Cure target by volume."
    },
    {
      "id": "A-v2-4-002",
      "headline": "O*NET: Medical Records 97% automation (186K jobs). Paralegals 90% (355K jobs). Claims Adjusters 63% (294K jobs). RNs only 10% -- confirms Baumol Premium.",
      "structural_shift": "Polanyi Classification -- Healthcare/Legal/Insurance validated",
      "source": "O*NET / WillRobotsTakeMyJob / BLS OES May 2024",
      "source_url": "https://willrobotstakemyjob.com/medical-records-specialists",
      "relevance_score": 10,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "production_cost_shift",
      "barriers_noted": [],
      "category": "services",
      "detail": "HEALTHCARE: Medical Records 97% automation (185,690 employed, $48,780) -- 'imminent risk, nearly all tasks routine-cognitive'. RNs 10% automation (3,175,390 employed, $86,070) -- CONFIRMS Baumol Premium, NOT Baumol Cure. Human-touch, empathy, physical presence required. LEGAL: Paralegals 90% (354,890 employed, $60,970) -- 'no important qualities that can't be easily automated'. Lawyers 23% (731,340 employed, $145,760) -- judgment, persuasion, negotiation resist automation. INSURANCE: Claims Adjusters 63% (293,780, $75,050) -- social perceptiveness + negotiation resist; document interpretation automatable. Insurance Sales 80% (457,510, $59,080) -- routine sales automatable but persuasion/negotiation resist."
    },
    {
      "id": "A-v2-4-003",
      "headline": "O*NET Manufacturing: Machinists 79% automation risk but 'manual dexterity' resists (291K jobs, $51K). Production Supervisors blend of judgment + routine.",
      "structural_shift": "Polanyi Classification -- Manufacturing occupations confirm PARTIAL automation thesis",
      "source": "O*NET / WillRobotsTakeMyJob / BLS OES May 2024",
      "source_url": "https://willrobotstakemyjob.com/machinists",
      "relevance_score": 9,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "production_cost_shift",
      "barriers_noted": [],
      "category": "physical_production",
      "detail": "MANUFACTURING: Machinists 79% calculated automation risk (290,720 employed, $50,840) BUT 'manual dexterity' and 'finger dexterity' are hard-to-automate qualities. User poll only 54% think replacement likely. CNC automation already transformed field -- skilled machinists now program and set up, not just operate. THIS VALIDATES cycle 3 finding: manufacturing automation is PARTIAL (enhances, doesn't replace). Cobots handle repetitive physical tasks while machinists handle setup, programming, QC. The 30% routine-cognitive (measurements, program input, QC checks) IS automatable by AI; the 50% tacit-manual requires human-robot collaboration."
    },
    {
      "id": "A-v2-4-004",
      "headline": "Baumol Signal Matrix: Highest wage x automation exposure = Accountants ($80K x 67% = $53.6K automatable wage). Bookkeepers $47K x 91% = $43.2K. Claims Adjusters $75K x 63%.",
      "structural_shift": "BLS Wage x O*NET Automation = Baumol Cure Priority Ranking",
      "source": "BLS OES May 2024 + O*NET/WillRobotsTakeMyJob composite",
      "source_url": "https://www.bls.gov/oes/2024/may/featured_data.htm",
      "relevance_score": 10,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "production_cost_shift",
      "barriers_noted": [],
      "category": "services",
      "detail": "BAUMOL CURE PRIORITY MATRIX (Annual Wage x Automation% x Employment = Total Automatable Wage Bill): 1. BOOKKEEPERS: $47K x 91% x 1.5M = $64.2B automatable wage bill. LARGEST target by total value. 2. ACCOUNTANTS: $80K x 67% x 1.4M = $75.0B automatable wage bill. Highest per-worker value but lower automation %. 3. MEDICAL RECORDS: $49K x 97% x 186K = $8.8B. Small employment but highest automation rate. 4. PARALEGALS: $61K x 90% x 355K = $19.5B. 5. CLAIMS ADJUSTERS: $75K x 63% x 294K = $13.9B. 6. TAX PREPARERS: $49K x 99% x 82K = $4.0B. Small market but near-total automation. 7. INSURANCE SALES: $59K x 80% x 458K = $21.6B. TOTAL across 7 occupations: ~$207B in automatable wages. Validates Tier 1 accounting opportunity: bookkeepers + accountants alone = $139B automatable wage base. BAUMOL PREMIUM: RNs at 10% automation x $86K x 3.2M = only $27.5B automatable (90% HUMAN PREMIUM = $247B in human-premium wage base). Lawyers at 23% x $146K x 731K = $24.6B automatable but $82B in judgment-premium wages. The Baumol split is CONFIRMED: cure targets in admin/clerical, premium targets in clinical/judgment roles."
    },
    {
      "id": "A-v2-4-005",
      "headline": "STRESS TEST #1 -- SMB Accounting: Bench collapsed Dec 2024 ($113M raised, 35K customers). Intuit launching AI agents + Accountant Suite. Full-service gap remains but narrowing.",
      "structural_shift": "SMB Accounting Full-Service -- Stress Test: Who's already doing this?",
      "source": "TechCrunch / Intuit / CPA Practice Advisor",
      "source_url": "https://techcrunch.com/2024/12/27/bench-shuts-down-leaving-thousands-of-businesses-without-access-to-accounting-and-tax-docs/",
      "relevance_score": 10,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "competitive_saturation",
      "barriers_noted": ["bench_failure_warning", "intuit_competitive_threat", "full_service_complexity"],
      "category": "services",
      "detail": "STRESS TEST on #1 opportunity. BEAR CASE FINDINGS: (1) Bench Accounting COLLAPSED Dec 2024 despite $113M raised, 35K customers. Root cause: couldn't balance tech + service at scale, wasn't profitable despite premium pricing. This is the #1 precedent failure for AI full-service bookkeeping. (2) Intuit launching 'Intuit Accountant Suite' as AI-native platform, plus AI agents for QuickBooks that handle bookkeeping, reconciliation, invoicing. Saves 12 hrs/month. Accelerate plan $149/month. (3) Zeni ($549+/mo) and Botkeeper are AI+offshore human hybrid models. (4) Only 16% of accounting firms operationally deployed AI. WHAT COULD KILL IT: Intuit adds full-service capability to QuickBooks, leveraging 7M+ existing SMB customer base. They have distribution, trust, and data that no startup can match. LIKELIHOOD: MEDIUM-HIGH. Intuit is explicitly moving this direction with AI agents. HOWEVER: Bench's failure actually VALIDATES the difficulty and creates a moat for whoever solves the operational model. Intuit's AI agents are still tools, not full-service. The gap between 'AI helps you do bookkeeping' and 'AI does your bookkeeping' remains. Score adjustment: -2 (Intuit threat + Bench precedent)."
    },
    {
      "id": "A-v2-4-006",
      "headline": "STRESS TEST #2 -- Manufacturing Acquisition: Cobot ROI 8-14 months confirmed. 35% cobot adoption surge. BUT: skilled integration labor is bottleneck, not equipment.",
      "structural_shift": "Manufacturing Acquisition -- Stress Test: What if cobot ROI is overstated?",
      "source": "Standard Bots / ManTec / Revopoint / IDTechEx",
      "source_url": "https://standardbots.com/blog/robots-for-manufacturers-a-guide",
      "relevance_score": 9,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "manufacturing_disruption",
      "barriers_noted": ["integration_labor_bottleneck", "operator_training", "process_specificity"],
      "category": "physical_production",
      "detail": "STRESS TEST on #3 opportunity (Manufacturing Acquisition). BEAR CASE FINDINGS: (1) Cobot ROI data CONFIRMED: 8-14 months average payback, 35% cobot adoption surge in 2024, single cobot saves $65-85K/yr in direct labor. Industry data says 12-36 months for general manufacturing robots, 6-12 months for cobots. (2) WHAT COULD KILL IT: OPERATIONAL COMPLEXITY. The 70% M&A synergy failure rate is the real risk -- not the cobot ROI. Acquiring a manufacturing business and SIMULTANEOUSLY modernizing it with cobots requires dual expertise (operations management + automation engineering). The bottleneck is not equipment (cobots are commodity, $30-55K each) but SKILLED INTEGRATION: programming, workflow redesign, operator training. (3) Tariff uncertainty could affect input costs. (4) 12-18 month realistic integration timeline means 18+ months before modernization benefits materialize. REALISTIC FAILURE MODE: Acquiring a business that looks good on paper but has hidden operational issues (customer concentration, equipment condition, key-man dependencies) and then struggling with integration while carrying debt service. LIKELIHOOD: MEDIUM. Mitigated by targeting retirement sales (cleaner operations, motivated sellers) and keeping modernization capital separate from acquisition. Score adjustment: -1 (integration complexity acknowledged but cobot ROI validated)."
    },
    {
      "id": "A-v2-4-007",
      "headline": "STRESS TEST #3 -- Specialty Food: FDA PCHF compliance $22K first year, $8K/yr ongoing. Margins ARE thin (5-10% for commodity, 20-35% for specialty). Scale is the constraint.",
      "structural_shift": "Specialty Food Production -- Stress Test: Are margins too thin?",
      "source": "Food Safety / FDA / Food Industry Executive",
      "source_url": "https://www.food-safety.com/articles/9776-study-pchf-compliance-costs-small-and-midsized-food-businesses-22-000-in-first-year-alone",
      "relevance_score": 9,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "manufacturing_disruption",
      "barriers_noted": ["FDA_compliance_cost", "thin_margins_if_commodity", "food_traceability_2026"],
      "category": "physical_production",
      "detail": "STRESS TEST on #4 opportunity. BEAR CASE FINDINGS: (1) FDA PCHF compliance: $22K first year implementation, $8K annually ongoing for small/mid businesses. For qualified facilities with modified requirements: $300-$2,000/yr. NEW in 2026: food traceability rule (FSMA 204) now enforceable -- additional recordkeeping requirements. (2) MARGINS: commodity food production 5-10% net (too thin for modernization ROI). Specialty/branded food 20-35% (viable). The wholesale bakery target at 29% margin IS specialty, NOT commodity. (3) WHAT COULD KILL IT: If the acquired operation is commodity-positioned (private label, price-competitive), margins are too thin to justify modernization. If ingredient costs spike (wheat, sugar, dairy volatile), the margin buffer disappears. FDA certification transfer for acquired facilities can take 3-6 months, during which production may need to continue under existing certifications. (4) EMERGING RISK: PFAS/microplastics concerns could trigger new testing requirements, adding cost. (5) 2026 packaging compliance (Extended Producer Responsibility) adds cost in some states. LIKELIHOOD OF FAILURE: LOW-MEDIUM if targeting specialty/branded (20-35% margins), HIGH if targeting commodity (5-10% margins). The key discriminator is BRAND and DISTRIBUTION, not production efficiency. Score adjustment: -1 (margin risk real but mitigated by specialty focus)."
    },
    {
      "id": "A-v2-4-008",
      "headline": "Under-Explored #1 -- Government/Municipal AI: $26.4B market growing to $136B by 2035. 82% state CIOs using GenAI. BUT: procurement cycles 12-24 months, FedRAMP barrier.",
      "structural_shift": "Government AI -- Baumol Cure candidate assessed",
      "source": "Grand View Research / NASCIO / GovTech / Deloitte",
      "source_url": "https://www.grandviewresearch.com/industry-analysis/ai-government-public-services-market-report",
      "relevance_score": 8,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "liquidation_cascade",
      "barriers_noted": ["procurement_cycle_12_24_months", "FedRAMP_authorization", "budget_constraints", "political_risk"],
      "category": "services",
      "detail": "UNDER-EXPLORED SECTOR ASSESSMENT: Government/Municipal AI. STRUCTURAL FORCE: YES, strong Baumol force. Government services have experienced above-CPI cost growth for decades. Labor-intensive admin (permitting, licensing, citizen services, records management) is 70%+ routine-cognitive. Market $26.4B (2025) growing to $135.7B by 2035 at 17.8% CAGR. 82% of state CIOs using GenAI in daily work. Y Combinator funded 35 GovTech startups. INCUMBENTS: OpenGov (acquired by Cox, $182M raised), Mark43 ($269M raised for public safety), Tyler Technologies ($1.8B revenue). BARRIERS: (1) Procurement cycles 12-24 months (vs 1-3 months for SMB). (2) FedRAMP authorization for federal, StateRAMP emerging. (3) Data sensitivity (CJIS for criminal justice, HIPAA for health). (4) Budget cycles create revenue lumpiness. (5) Political risk to AI adoption. VERDICT: TIER 3 candidate. Strong structural force but procurement cycles and security requirements are NOT moats (they're barriers without clear moat potential for a startup). For a 2-person team, the sales cycle is incompatible with runway. Better served by larger companies (Tyler Technologies, OpenGov). NOT recommended for landscape promotion. Keep in Monitoring."
    },
    {
      "id": "A-v2-4-009",
      "headline": "Under-Explored #2 -- Mental Health AI: Woebot SHUT DOWN (Jul 2025) after $123M raised. FDA pathway killed it. Utah law creates regulatory moat. Slingshot $93M, MindSync $720M.",
      "structural_shift": "Mental Health AI -- Regulatory moat forming but FDA pathway blocked",
      "source": "STAT News / Utah Legislature / Behavioral Health Business / Crunchbase",
      "source_url": "https://www.statnews.com/2025/07/02/woebot-therapy-chatbot-shuts-down-founder-says-ai-moving-faster-than-regulators/",
      "relevance_score": 9,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "regulatory_moat",
      "barriers_noted": ["FDA_pathway_unclear", "clinical_liability", "state_regulation_fragmentation", "woebot_failure_precedent"],
      "category": "services",
      "detail": "UNDER-EXPLORED SECTOR ASSESSMENT: Mental Health AI. STRUCTURAL FORCE: VERY STRONG. Massive Baumol force -- therapy costs $150-300/session, 60%+ of counties are mental health professional shortage areas, demand surging post-pandemic. Jevons potential 5-10x (hundreds of millions need therapy but can't access/afford it). COMPETITIVE LANDSCAPE: CRITICAL UPDATE: Woebot Health SHUT DOWN its therapy chatbot (July 2025) after $123M raised. CEO said 'AI is moving faster than regulators.' FDA pathway for digital therapeutics proved too costly and slow. Slingshot AI raised $93M for AI-powered therapy. MindSync at $720M total funding, 8M users. Talkiatry $130M (psychiatry, not pure AI). REGULATORY: Utah HB 452 (effective May 2025) creates first-in-nation mental health chatbot regulation -- disclosure requirements, data protection, advertising restrictions. This is a REGULATORY MOAT forming. VERDICT: TIER 2 candidate. Massive structural force (potentially largest Jevons expansion of any sector at 5-10x). But Woebot's failure is a CRITICAL warning -- FDA pathway for clinical AI therapy is blocked. The opportunity is NOT in FDA-regulated therapy replacement. It's in: (a) therapist productivity tools (AI documentation, intake, scheduling), (b) sub-clinical wellness/coaching (no FDA), (c) compliance platform for Utah-style regulations as they spread to other states. PROMOTE from Monitoring to Tier 3, flag for potential Tier 2 if regulatory landscape clarifies."
    },
    {
      "id": "A-v2-4-010",
      "headline": "Under-Explored #3 -- Real Estate AI: $10.5B funding in 2025 (+17%). EliseAI $250M at $2.25B valuation. 7 unicorns. VERY CROWDED competitive landscape.",
      "structural_shift": "Real Estate Transaction AI -- Competitive density assessment",
      "source": "Crunchbase / Morgan Stanley / Substack (The Appraisal)",
      "source_url": "https://news.crunchbase.com/real-estate-property-tech/rebound-ai-fintech-data-eoy-2025/",
      "relevance_score": 8,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "competitive_saturation",
      "barriers_noted": ["hyper_competitive", "7_unicorns", "capital_intensive"],
      "category": "services",
      "detail": "UNDER-EXPLORED SECTOR ASSESSMENT: Real Estate Transaction AI. STRUCTURAL FORCE: MODERATE. Real estate transactions involve significant admin overhead (title search, document prep, compliance, agent coordination). Some Baumol force but lower than healthcare/accounting. COMPETITIVE LANDSCAPE: EXTREMELY CROWDED. $10.5B startup funding in 2025 (+17% YoY). EliseAI at $2.25B valuation ($250M Series E). Bilt Rewards at $13B valuation. 7 companies at unicorn/near-unicorn status. Top 50 AI startups mapped in real estate. Morgan Stanley projecting $34B in AI efficiency gains for the sector. VERDICT: NOT Tier 1 or Tier 2 material. Competitive density is the highest of any sector we've assessed. Massive capital already deployed. 7 unicorns means the opportunity window for new entrants is CLOSED at the platform level. Niche opportunities might exist (e.g., title AI, escrow automation) but the sector is saturated. KEEP in Monitoring but do NOT promote. Remove from under-explored list -- it's been explored and found to be too crowded."
    },
    {
      "id": "A-v2-4-011",
      "headline": "Intuit Accountant Suite: AI-native platform replacing QBO Accountant. AI agents for bookkeeping, reconciliation, invoicing. Accelerate plan $149/mo. Transition by Dec 2026.",
      "structural_shift": "Embedded AI Commoditization Accelerating -- Intuit's full platform pivot",
      "source": "Intuit / CPA Practice Advisor / Firm of the Future",
      "source_url": "https://www.cpapracticeadvisor.com/2026/02/09/intuit-is-discontinuing-quickbooks-online-accountant-and-replacing-it-with-intuit-accountant-suite/177698/",
      "relevance_score": 10,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "competitive_saturation",
      "barriers_noted": ["intuit_direct_competitor_at_service_layer"],
      "category": "services",
      "detail": "CRITICAL COMPETITIVE UPDATE: Intuit is discontinuing QuickBooks Online Accountant and replacing it with Intuit Accountant Suite -- an AI-native platform. This is NOT just adding AI features to existing product (sustaining innovation). This is a PLATFORM REPLACEMENT with AI at the core. AI agents handle bookkeeping, reconciliation, invoicing, financial analysis. Accelerate plan at $149/month. Transition: free Core plan for existing users summer-Dec 2026, then Accelerate paid at $149/month starting May 1, 2026. IMPLICATION FOR ACCOUNTING OPPORTUNITY: Intuit is moving from tool-layer to SERVICE-LAYER. The Christensen three-layer framework's 'safe zone' (service/full-service layer) is now under direct pressure from the largest incumbent. Intuit has 7M+ SMB customers, trusted brand, and distribution. HOWEVER: Intuit Accountant Suite still serves ACCOUNTING FIRMS, not end SMBs directly. The full-service layer (AI doing bookkeeping FOR the SMB, no accountant intermediary) is still empty. And Intuit's pricing at $149/month for ACCOUNTANTS means the SMB price will be higher. Direct-to-SMB at $99-199/month for full-service remains a viable play."
    },
    {
      "id": "A-v2-4-012",
      "headline": "CA AB 1175 signed Oct 2025: CPA licensing modernized. New pathway effective Jan 2027. Bachelor's + exam + 2yr experience. Master's substitutes for 1yr. LOWERS barrier.",
      "structural_shift": "CPA Licensing Barrier -- LOWERING in California",
      "source": "CalCPA / CBA / Inside Public Accounting / CFO Dive",
      "source_url": "https://www.calcpa.org/whats-happening/press/governor-signs-ab-1175-modernizing-cpa-licensure-in-california",
      "relevance_score": 8,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "regulatory_capture_weakening",
      "barriers_noted": ["still_requires_CPA_exam", "2yr_experience_requirement"],
      "category": "services",
      "detail": "CA AB 1175 signed into law October 3, 2025. Effective January 1, 2027 (with transition through 2028). KEY CHANGES: Replaces 150 credit-hour requirement with bachelor's degree + accounting concentration + CPA exam + 2 years experience. Master's degree substitutes for 1 year experience. Accounting certificate program substitutes for 6 months. WHY THIS MATTERS: This LOWERS the barrier to CPA licensure in CA, addressing the pipeline crisis (75% of CPAs nearing retirement). For an AI-first accounting firm: (1) Still need at least one CPA for compliance/sign-off, (2) Acquiring a small CPA practice ($50-300K) remains the fastest path, (3) AB 1175 increases the supply of new CPAs in 2027-2028, potentially lowering acquisition costs for CPA practices. MOAT IMPLICATION: The barrier is lowering but still exists. CPA licensure remains a meaningful moat for 2-3 years until new supply materializes."
    },
    {
      "id": "A-v2-4-013",
      "headline": "Bench Accounting collapsed Dec 2024: $113M raised, 35K customers, never profitable. Root cause: couldn't scale hybrid AI+human model. P4 Dead Business Revival signal.",
      "structural_shift": "Dead Business Revival -- Bench's failure validates the market, reveals the failure mode",
      "source": "TechCrunch / Wiss / AccountingProse / EisnerAmper",
      "source_url": "https://techcrunch.com/2024/12/27/bench-shuts-down-leaving-thousands-of-businesses-without-access-to-accounting-and-tax-docs/",
      "relevance_score": 9,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "dead_revival",
      "barriers_noted": ["unit_economics_at_scale", "hybrid_model_complexity"],
      "category": "services",
      "detail": "P4 DEAD BUSINESS REVIVAL ANALYSIS: Bench Accounting collapsed Dec 2024 despite $113M raised and 35K customers. FAILURE MODE: (1) Bench relied on AI + offshore human team (Philippines). The human cost floor meant they couldn't achieve profitability at their pricing. (2) Couldn't handle complexity scaling -- worked for simple SMBs but broke for growing businesses. (3) Leadership vacuum after co-founder departed 2021. (4) Tried to be both tech company and service provider -- failed at both. WHY THIS IS A P4 POSITIVE SIGNAL: Bench proved the MARKET exists (35K customers, $113M of VC believed in it). The failure was COST STRUCTURE (human labor floor) and OPERATIONAL (leadership, scaling). AI inference costs have dropped 200x since Bench's model was designed. A pure-AI-first model (not AI+offshore human) with $0.05/month inference costs addresses Bench's core failure. Bench's 35K orphaned customers are a direct acquisition target. The market learned what doesn't work; the AI economics now enable what does."
    },
    {
      "id": "A-v2-4-014",
      "headline": "Cobot adoption surged 35% in 2024. Average ROI 195 days (one major manufacturer). Cobots now 30% of new robotic installations (up from 5% a decade ago).",
      "structural_shift": "Robotics x AI -- Cobot adoption inflection point confirmed",
      "source": "Standard Bots / ManTec / IDTechEx / SORA Robotic",
      "source_url": "https://standardbots.com/blog/robots-for-manufacturers-a-guide",
      "relevance_score": 8,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "robotics_ai_convergence",
      "barriers_noted": [],
      "category": "physical_production",
      "detail": "COBOT ADOPTION DATA UPDATE: 35% surge in collaborative robot adoption in 2024. Cobots now represent ~30% of all new robotic installations (up from <5% a decade ago). Average ROI: 12-18 months for well-implemented projects. One leading manufacturer reports 195-day average ROI across customer base. Single cobot replacing one full-time operator saves $65-85K annually. Cycle time reduction 15-30%. Defect rate reduction 40-60%. Cost per station: $35-90K installed. Installation time dropping to 1 week. IMPLICATION: Cobot economics have crossed the viability threshold for SME manufacturers. The constraint is no longer cost (cobots are cheap) or ROI (proven). The constraint is INTEGRATION CAPABILITY -- who can help SME manufacturers deploy cobots effectively? This validates the Manufacturing AI Integration Service model."
    },
    {
      "id": "A-v2-4-015",
      "headline": "Woebot Health SHUT DOWN therapy chatbot July 2025. CEO: 'AI moving faster than regulators.' FDA digital therapeutics pathway too costly and slow.",
      "structural_shift": "Mental Health AI -- FDA pathway BLOCKED. Sub-clinical and productivity tools viable.",
      "source": "STAT News / New Atlas / AI Fund",
      "source_url": "https://www.statnews.com/2025/07/02/woebot-therapy-chatbot-shuts-down-founder-says-ai-moving-faster-than-regulators/",
      "relevance_score": 9,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "regulatory_moat",
      "barriers_noted": ["FDA_pathway_blocked", "clinical_liability"],
      "category": "services",
      "detail": "CRITICAL: Woebot Health, the pioneer of AI therapy chatbots ($123M raised), shut down its signature chatbot in July 2025. CEO Alison Darcy: 'AI is moving faster than regulators can keep up.' The FDA's requirements for marketing authorization proved too costly and slow. IMPLICATION: Direct AI therapy replacement is BLOCKED by regulatory barriers. But this creates a MOAT for compliant entrants. The opportunity shifts to: (1) Therapist productivity tools (AI documentation, intake, treatment planning) -- no FDA needed. (2) Sub-clinical wellness and coaching (explicitly not therapy) -- avoid FDA. (3) Regulatory compliance platform for mental health AI as states follow Utah. Woebot's failure is EXACTLY the kind of P4 signal the engine looks for: the market exists (mental health crisis is real), the failure was cost/regulatory structure, and the structure is evolving."
    },
    {
      "id": "A-v2-4-016",
      "headline": "BLS Baumol Signal: Professional/Technical Services avg hourly earnings $45.66 (May 2024), up ~4%/yr. Healthcare $34.26, up ~3.5%/yr. Both outpacing CPI (~2.5%).",
      "structural_shift": "Baumol Stored Energy -- BLS wage growth continues above CPI",
      "source": "BLS Current Employment Statistics / OEWS May 2024",
      "source_url": "https://www.bls.gov/oes/2024/may/featured_data.htm",
      "relevance_score": 8,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "production_cost_shift",
      "barriers_noted": [],
      "category": "services",
      "detail": "BLS WAGE DATA confirms continued Baumol premium accumulation. Professional and Technical Services avg hourly earnings: $45.66 (growing ~4%/yr, consistently above CPI ~2.5%). Healthcare: $34.26 (growing ~3.5%/yr). Financial Activities: $39.26 (growing ~3.8%/yr). Education: $29.14 (growing ~3.2%/yr). ALL above CPI. Each year of above-CPI wage growth adds more 'stored potential energy' to the Baumol Cure opportunity. The gap between human labor cost growth and AI inference cost decline is WIDENING. At 4% wage growth vs. 50%+ annual inference cost decline, the cost advantage ratio doubles roughly every 18 months."
    },
    {
      "id": "A-v2-4-017",
      "headline": "BLS Employment Projections 2024-2034: Claims Adjusters -5%, Bookkeepers -5%, Machinists -2%. Tax Preparers +4.2%. Medical Records +8.7%. RNs +5%.",
      "structural_shift": "BLS Employment Outlook -- Pre-cascade signals in bookkeeping and claims",
      "source": "BLS Employment Projections 2024-2034",
      "source_url": "https://www.bls.gov/news.release/pdf/ecopro.pdf",
      "relevance_score": 8,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "liquidation_cascade",
      "barriers_noted": [],
      "category": "services",
      "detail": "BLS employment projections 2024-2034 provide pre-cascade indicators: DECLINING: Bookkeepers -5% (automation displacement), Claims Adjusters -5% (AI claims processing), Machinists -2% (CNC automation). GROWING: Medical Records +8.7% (demand outpacing automation despite 97% automation potential -- transition period), Tax Preparers +4.2% (counter-intuitive -- may reflect growing tax complexity), RNs +5% (demographic demand). DIVERGENCE SIGNAL: Medical Records growing despite 97% automation probability = the displacement hasn't happened yet. This is exactly the Schumpeterian gap period -- the occupation is 'dead but doesn't know it yet.' The 185K workers in medical records represent a $9B wage bill that will compress over the next 5-10 years. Similarly, the 1.5M bookkeepers declining at only -5% means the displacement is EARLY -- the window is open."
    },
    {
      "id": "A-v2-4-018",
      "headline": "Manufacturing workforce data 2025-2026: total employer compensation $46.30/hr (Q2 2025). Skills gap (not headcount) is #1 constraint. 12.69M employed, softening.",
      "structural_shift": "Manufacturing Labor -- Skills gap validates integration service model",
      "source": "BLS ECEC / AMTEC Manufacturing Workforce Data 2025-2026",
      "source_url": "https://www.amtec.us.com/blog/manufacturing-workforce-report",
      "relevance_score": 7,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "demographic_gap",
      "barriers_noted": ["skills_gap_limits_adoption"],
      "category": "physical_production",
      "detail": "Manufacturing workforce: total employer compensation averages $46.30/hr (Q2 2025), with benefits ~1/3 of total. Employment softened to 12.69M. The constraint has shifted from HEADCOUNT to SKILLS -- 1/3 of manufacturing executives cite workforce skills as top concern (Deloitte). This validates the INTEGRATION SERVICE business model: manufacturers have the workers and the budget, but lack the skills to deploy AI/robotics effectively. The gap between 'want to automate' (98% exploring) and 'have automated' (20% prepared) is a SKILLS gap, not a COST gap."
    },
    {
      "id": "A-v2-4-019",
      "headline": "Food production economics 2026: raw materials volatility is #1 risk. Tariffs, rates, supply chain disruption. Specialty/branded 20-35% margins; commodity 5-10%.",
      "structural_shift": "Food Production -- Input cost volatility is the margin killer",
      "source": "Food Industry Executive / Armstrong Teasdale / AlleraTech",
      "source_url": "https://foodindustryexecutive.com/2025/12/rates-raw-materials-and-risk-economic-considerations-for-food-manufacturers-in-2026/",
      "relevance_score": 7,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "manufacturing_disruption",
      "barriers_noted": ["raw_material_volatility", "tariff_risk", "rate_sensitivity"],
      "category": "physical_production",
      "detail": "2026 food production economics: rates, raw materials, and risk are the three forces shaping margins. Raw material costs volatile (wheat, dairy, sugar subject to weather, trade policy, supply chain). Tariff uncertainty adds input cost risk. Interest rates affect equipment financing costs. Specialty/branded producers maintain 20-35% margins (pricing power from brand/distribution). Commodity producers at 5-10% margins (price-takers). NEW 2026 RISKS: FSMA 204 food traceability rule enforceable, packaging compliance (EPR), emerging contaminant concerns (PFAS, microplastics). IMPLICATION: The food production acquisition play MUST target specialty/branded (not commodity). Brand and distribution are the moat, not production efficiency alone. A wholesale bakery with 300+ store distribution and 29% margins is correctly positioned. A commodity private-label producer is NOT."
    },
    {
      "id": "A-v2-4-020",
      "headline": "Mental Health AI competitive landscape: MindSync $720M funded/8M users. Slingshot $93M. Talkiatry $130M (psychiatry). Woebot dead. Utah regulating. 5+ states following.",
      "structural_shift": "Mental Health AI -- Massive unmet demand, regulatory moat forming, clinical AI pathway blocked",
      "source": "Guru Startups / Behavioral Health Business / Crunchbase / Utah Legislature",
      "source_url": "https://bhbusiness.com/2025/07/22/with-93m-raised-slingshot-slingshot-ai-debuts-ai-powered-therapy-service/",
      "relevance_score": 8,
      "timestamp": "2026-02-10T23:59:00Z",
      "status": "modeled",
      "signal_type": "regulatory_moat",
      "barriers_noted": ["FDA_barrier_for_clinical", "state_regulation_spreading"],
      "category": "services",
      "detail": "Mental health AI landscape mapped: MindSync ($720M total funding, 8M users, Series D $250M), Slingshot AI ($93M, AI-powered therapy), Talkiatry ($130M, a16z-backed, psychiatry platform), Wysa (consumer chat-based), Woebot (DEAD, $123M raised but shut down). Utah HB 452 creates first state regulation of mental health chatbots (May 2025). Other states likely to follow. FDA pathway for clinical digital therapeutics remains unclear/blocked. The opportunity splits: (1) Consumer wellness (sub-clinical, no FDA, huge Jevons at $10-30/month vs $150-300/session), (2) Therapist productivity tools (documentation, intake, matching), (3) Compliance platform for state-by-state mental health AI regulation. The $150B+ unmet mental health need is the LARGEST Jevons expansion opportunity by ratio (potential 10-50x market expansion at 10x lower cost). But clinical AI therapy is regulatory-blocked. The indirect plays are more viable."
    }
  ]
}
